Exegenesis Bio

Developer of cell and gene therapies to treat multiple diseases

placePhiladelphia, Pennsylvania, United States calendar_todayFounded 2019 groups22 employees language exegenesisbio.com

Registered entities

Innovation

4 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace active. Cited 25 times.

YearFilings
20242
20252
20261

Social engagement

Social engagement: 1.7K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

12 investors on record; lead investors include Legend Capital, K2VC.

Investor typeCountShare
Venture capital758%
Private equity217%
Other / undisclosed325%
Coming soon